Citations

Showing 10 of 108094 citations.

Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function
Pottel, Hans , Cavalier, Etienne , Björk, Jonas , Grubb, Anders , Ebert, Natalie , Schäeffner, Elke , Melsom, Toralf , Lamb, Edmund J. , Mariat, Christophe , Dubourg, Laurence , Hansson, Magnus , Littmann, Karin , Sundin, Per‐Ola , Åkesson, Anna , Ebert, Natalie , Sundin, Per-Ola , Delanaye, Pierre , Grubb, Anders , Schaeffner, Elke , Björk, Jonas , Nyman, Ulf , Eriksen, Björn O. , Larsson, Anders , Rule, Andrew D. , Delanaye, Pierre

Mayo Clinic

Clinical Kidney Journal | August 3, 2022 | Volume: 15 | Issue: 12 | Pages: 2258-2265

10.1093/ckj/sfac182 | PMID 36381377 Get It

ABSTRACT Background Differences in the performance of estimated glomerular filtration rate (eGFR) equations have been attributed to the mathematical form of the equations and to differences between patient demographics and measurement methods. We evaluated differences in serum creatinine (SCr) and eGFR in cohorts matched for age, sex, body mass index (BMI) and measured GFR (mGFR). Methods White North Americans from Minnesota (n = 1093) and the Chronic Renal Insufficiency Cohort (CRIC) (n = 1548) and White subjects from the European Kidney Function Consortium (EKFC) cohort (n = 7727) were matched for demographic patient characteristics (sex, age ± 3 years, BMI ± 2.5 kg/m2) and renal function (mGFR ± 3 ml/min/1.73 m2). SCr was measured with isotope dilution mass spectrometry (IDMS)-traceable assays in the Minnesota and EKFC cohorts and with non-standardized SCr assays recalculated to IDMS in the CRIC. The Minnesota cohort and CRIC shared a common method to measure GFR (renal clearance of iothalamate), while the EKFC cohort used a variety of exogenous markers and methods, all with recognized sufficient accuracy. We compared the SCr levels and eGFR predictions [for Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and EKFC equations] of patients fulfilling these matching criteria. Results For 305 matched individuals, mean SCr (mg/dL) was not different between the Minnesota and EKFC cohorts (females 0.83 ± 0.20 versus 0.86 ± 0.23, males 1.06 ± 0.23 versus 1.12 ± 0.37; P > .05) but significantly different from the CRIC [females 1.13 ± 0.23 (P < .0001), males 1.42 ± 0.31 (P < .0001)]. The CKD-EPI equations performed better than the EKFC equation in the CRIC, while the opposite was true in the Minnesota and EKFC cohorts. Conclusion Significant differences in SCr concentrations between the Minnesota and EKFC cohorts versus CRIC were observed in subjects with the same level of mGFR and equal demographic characteristics and can be explained by the difference in SCr calibration.
The broader prospects for bispecifics in Hodgkin lymphoma
Chohan, Karan , Ansell, Stephen M. , Chohan, Karan L, Chohan, Karan L

Mayo Clinic

Leukemia & Lymphoma | August 3, 2022 | Volume: 63 | Issue: 8 | Pages: 1777-1779

10.1080/10428194.2022.2107205 | PMID 35920699 Get It

Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors
Katsuta, Eriko , Gil‐Moore, Malgorzata, Moore, Justine , Yousif, Mohamed, Adjei, Alex A. , Caserta, Justin, Baldino, Carmen M., Gil-Moore, Malgorzata, Yousif, Mohamed, Ding, Yi , Lee, Kelvin H. , Gelman, Irwin H. , Takabe, Kazuaki , Opyrchal, Mateusz

Mayo Clinic

International Journal of Oncology | August 3, 2022 | Volume: 61 | Issue: 4 | Pages: No page available

10.3892/ijo.2022.5404 | PMID 35920189 Get It

Sex Differences in the Impact of Aortic Valve Calcium Score on Mortality After Transcatheter Aortic Valve Replacement
Patel, Parth P., Sabbagh, Abdallah El , Johnson, Patrick W. , Suliman, Rayan , Salwa, Najiyah, Morales-Lara, Andrea Carolina , Pollak, Peter , Yamani, Mohamad H. , Parikh, Pragnesh , Sonavane, Sushilkumar K. , Landolfo, Carolyn, Eleid, Mackram F. , Fortuin, F. David , Sweeney, John P., Carter, Rickey E. , Yamani, Mohamad H , Alkhouli, Mohamad , Eleid, Mackram F , Guerrero, Mayra E , Fortuin, Floyd David , Sweeney, John , Noseworthy, Peter A , Carter, Rickey E , Adedinsewo, Demilade A , Johnson, Patrick W , Patel, Parth P., Alkhouli, Mohamad , Guerrero, Mayra , Noseworthy, Peter A. , Adedinsewo, Demilade

Mayo Clinic

Circulation: Cardiovascular Imaging | August 3, 2022 | Volume: 15 | Issue: 8 | Pages: No page available

10.1161/circimaging.122.014034 | PMID 35920157 Get It

Background: Transcatheter aortic valve replacement (TAVR) is now an approved alternative to surgical aortic valve replacement for the treatment of severe aortic stenosis. As the clinical adoption of TAVR expands, it remains important to identify predictors of mortality after TAVR. We aimed to evaluate the impact of sex differences in aortic valve calcium score (AVCS) on long-term mortality following TAVR in a large patient sample. Methods: We included consecutive patients who successfully underwent TAVR for treatment of severe native aortic valve stenosis from June 2010 to May 2021 across all US Mayo Clinic sites with follow-up through July 2021. AVCS values were obtained from preoperative computed tomography of the chest. Additional clinical data were abstracted from medical records. Kaplan-Meier curves and Cox-proportional hazard regression models were employed to evaluate the effect of AVCS on long-term mortality. Results: A total of 2543 patients were evaluated in the final analysis. Forty-one percent were women, median age was 82 years (Q1: 76, Q3: 86), 18.4% received a permanent pacemaker following TAVR, and 88.5% received a balloon expandable valve. We demonstrate an increase in mortality risk with higher AVCS after multivariable adjustment ( P <0.001). When stratified by sex, every 500-unit increase in AVCS was associated with a 7% increase in mortality risk among women (adjusted hazard ratio, 1.07 [95% CI, 1.02–1.12]) but not in men. Conclusions: We demonstrate a notable sex difference in the association between AVCS and long-term mortality in a large TAVR patient sample. This study highlights the potential value of AVCS in preprocedural risk stratification, specifically among women undergoing TAVR. Additional studies are needed to validate this finding.
SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association
Al‐Mallah, Mouaz H. , Arrighi, James A., Bois, John P. , Carli, Marcelo F. Di , Dilsizian, Vasken , Gropler, Robert J. , Malhotra, Saurabh , Pelletier‐Galarneau, Matthieu , Woodard, Pamela K. , Chareonthaitawee, Panithaya , Al-Mallah, Mouaz H , Ruddy, Terrence D , Bluemke, David A. , Jadvar, Hossein , Schindler, Thomas Hellmut , Chareonthaitawee, Panithaya

Mayo Clinic

Circulation: Cardiovascular Imaging | August 3, 2022 | Volume: 15 | Issue: 8 | Pages: No page available

10.1161/circimaging.122.014576 | PMID 35920160 Get It

Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain
Moloney, Christina M. , Siddiqui, Habeeba, Castanedes‐Casey, Monica , Lachner, Christian , Petersen, Ronald C. , Duara, Ranjan , Graff‐Radford, Neill R. , Labuzan, Sydney A. , Crook, Julia E. , Murray, Melissa E , Duara, Ranjan , Dickson, Dennis W. , Mielke, Michelle M. , Murray, Melissa E.

Mayo Clinic

Alzheimer's & Dementia | August 3, 2022 | Volume: 19 | Issue: 3 | Pages: 1029-1040

10.1002/alz.12749 | PMID 35920592 Get It

Abstract Introduction Alzheimer's disease (AD) biomarkers are increasingly more reliable in predicting neuropathology. To facilitate interpretation of phosphorylated tau sites as an early fluid biomarker, we sought to characterize which neurofibrillary tangle maturity levels (pretangle, intermediary 1, mature tangle, intermediary 2, and ghost tangle) are recognized. Methods We queried the Florida Autopsied Multi‐Ethnic (FLAME) cohort for cases ranging from Braak stages I through VI, excluding non‐AD neuropathologies and tauopathies. Thioflavin‐S staining was compared to immunohistochemical measures of phosphorylated threonine (pT) 181, pT205, pT217, and pT231 in two hippocampal subsectors across n = 24 cases. Results Each phosphorylated tau site immunohistochemically labeled early neurofibrillary tangle maturity levels compared to advanced levels recognized by thioflavin‐S. Hippocampal burden generally increased with each Braak stage. Discussion These results provide neurobiologic evidence that these phosphorylated tau fluid biomarker sites are present during early neurofibrillary tangle maturity levels and may explain why these fluid biomarker measures are observed before symptom onset. Highlights Immunohistochemical evaluation of four phosphorylated tau fluid biomarker sites. Earlier neurofibrillary tangle maturity levels recognized by phosphorylated tau in proline‐rich region. Advanced tangle pathology is elevated in the subiculum compared to the cornu ammonis 1 of the hippocampus. Novel semi‐quantitative frequency to calculate tangle maturity frequency.
Correction: The quality of physical activity guidelines, but not the specificity of their recommendations, has improved over time: a systematic review and critical appraisal
Siedler, Madelin R. , Lamadrid, Priscila , Humphries, Megan N., Falck–Ytter, Yngve , Sultan, Shahnaz , Siedler, Madelin , Mustafa, Reem A , Dahm, Philipp , Murad, M. Hassan , Morgan, Rebecca L.

Mayo Clinic

Applied Physiology, Nutrition, and Metabolism | August 3, 2022 | Volume: 47 | Issue: 7 | Pages: 810-812

10.1139/apnm-2022-0236 | PMID 35920243 Get It

Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism
Minisola, Salvatore , Arnold, Andrew , Clarke, B.L. , Hannan, Fadil , Hofbauer, Lorenz C. , Liberman, Uri , Palermo, Andrea , Pepe, Jessica , Rizzoli, René , Wermers, Robert A. , Brandi, Maria Luisa , Clarke, Bart L , Hannan, Fadil M , Hofbauer, Lorenz C , Insogna, Karl , Palermo, Andrea , Pepe, Jessica , Wermers, Robert, Thakker, Rajesh V , Belaya, Zhanna E. , Brandi, Maria Luisa , Lacroix, André , Thakker, Rajesh V.

Mayo Clinic

Journal of Bone and Mineral Research | August 3, 2022 | Volume: 37 | Issue: 11 | Pages: 2315-2329

10.1002/jbmr.4665 | PMID 36245271 Get It

ABSTRACT In this narrative review, we present data gathered over four decades (1980–2020) on the epidemiology, pathophysiology and genetics of primary hyperparathyroidism (PHPT). PHPT is typically a disease of postmenopausal women, but its prevalence and incidence vary globally and depend on a number of factors, the most important being the availability to measure serum calcium and parathyroid hormone levels for screening. In the Western world, the change in presentation to asymptomatic PHPT is likely to occur, over time also, in Eastern regions. The selection of the population to be screened will, of course, affect the epidemiological data (ie, general practice as opposed to tertiary center). Parathyroid hormone has a pivotal role in regulating calcium homeostasis; small changes in extracellular Ca++ concentrations are detected by parathyroid cells, which express calcium-sensing receptors (CaSRs). Clonally dysregulated overgrowth of one or more parathyroid glands together with reduced expression of CaSRs is the most important pathophysiologic basis of PHPT. The spectrum of skeletal disease reflects different degrees of dysregulated bone remodeling. Intestinal calcium hyperabsorption together with increased bone resorption lead to increased filtered load of calcium that, in addition to other metabolic factors, predispose to the appearance of calcium-containing kidney stones. A genetic basis of PHPT can be identified in about 10% of all cases. These may occur as a part of multiple endocrine neoplasia syndromes (MEN1–MEN4), or the hyperparathyroidism jaw-tumor syndrome, or it may be caused by nonsyndromic isolated endocrinopathy, such as familial isolated PHPT and neonatal severe hyperparathyroidism. DNA testing may have value in: confirming the clinical diagnosis in a proband; eg, by distinguishing PHPT from familial hypocalciuric hypercalcemia (FHH). Mutation-specific carrier testing can be performed on a proband's relatives and identify where the proband is a mutation carrier, ruling out phenocopies that may confound the diagnosis; and potentially prevention via prenatal/preimplantation diagnosis. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). Abstract The prevalence and incidence of PHPT vary around the world and depend on a number of factors, the most important being availability of serum calcium (and parathyroid hormone) measurement for screening, which in the Western world has shifted its presentation to an asymptomatic disorder. Clonally dysregulated overgrowth of one or more parathyroid glands together with reduced expression of CaSRs is the most important pathophysiologic basis of PHPT, which may also occur as a part of inherited syndromes or as a nonsyndromic isolated endocrinopathy in 10% of cases. Genetic testing has roles in establishing the clinical diagnosis, although its value requires assessments using GRADE(176) methodology, which is recommended for future consideration.
An Individualized Recovery Task Checklist Which Served as an Educational Instrument in a Critically Ill and Intubated COVID-19 Patient
Stantz, Ashley , Emilio, Joel, Ahmad, Sumera , Garrison, Gregory M. , Boswell, Christopher L. , Zahidy, Misk Al, Garrison, Gregory M , Boswell, Christopher , Gajic, Ognjen

Mayo Clinic

Journal of Primary Care & Community Health | August 3, 2022 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/21501319221116249 | PMID 35920044 Get It

This case involves a patient with severe COVID-19 pneumonia and massive pulmonary embolism requiring mechanical ventilation. His clinical course was complicated by delirium likely triggered by his critical illness and failed initial extubation, isolation from family, and escalating fear and desperation. In hopeful preparation for subsequent successful extubation, a unique approach was taken to decrease the risk of panic, delirium, and decompensation leading to reintubation. As a means of orienting him to his treatment pathway and to provide encouragement for continued recovery, an impromptu patient-directed checklist was constructed. The recovery checklist, written in simplified language, outlined the stages of severe illness that the patient had overcome after his emergent intubation. The list also outlined the tasks he needed to complete prior to hospital discharge. Unexpectedly, the checklist received a great deal of engagement from both the patient and medical team and played an important role in this patient’s successful recovery and rehabilitation.
Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep Learning
Acosta, Paul H. , Panwar, Vandana, Jarmale, Vipul , Christie, Alana , Jasti, Jay, Margulis, Vitaly , Rakheja, Dinesh , Cheville, John C. , Leibovich, Bradley C. , Parker, Alexander S. , Brugarolas, James , Kapur, Payal , Rajaram, Satwik , Rakheja, Dinesh , Brugarolas, James , Kapur, Payal

Mayo Clinic

Cancer Research | August 3, 2022 | Volume: 82 | Issue: 15 | Pages: 2792-2806

10.1158/0008-5472.can-21-2318 | PMID 35654752 Get It

Abstract Intratumoral heterogeneity arising from tumor evolution poses significant challenges biologically and clinically. Dissecting this complexity may benefit from deep learning (DL) algorithms, which can infer molecular features from ubiquitous hematoxylin and eosin (H&E)–stained tissue sections. Although DL algorithms have been developed to predict some driver mutations from H&E images, the ability of these DL algorithms to resolve intratumoral mutation heterogeneity at subclonal spatial resolution is unexplored. Here, we apply DL to a paradigm of intratumoral heterogeneity, clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer. Matched IHC and H&E images were leveraged to develop DL models for predicting intratumoral genetic heterogeneity of the three most frequently mutated ccRCC genes, BAP1, PBRM1, and SETD2. DL models were generated on a large cohort (N = 1,282) and tested on several independent cohorts, including a TCGA cohort (N = 363 patients) and two tissue microarray (TMA) cohorts (N = 118 and 365 patients). These models were also expanded to a patient-derived xenograft (PDX) TMA, affording analysis of homotopic and heterotopic interactions of tumor and stroma. The status of all three genes could be inferred by DL, with BAP1 showing the highest sensitivity and performance within and across tissue samples (AUC = 0.87–0.89 on holdout). BAP1 results were validated on independent human (AUC = 0.77–0.84) and PDX (AUC = 0.80) cohorts. Finally, BAP1 predictions correlated with clinical outputs such as disease-specific survival. Overall, these data show that DL models can resolve intratumoral heterogeneity in cancer with potential diagnostic, prognostic, and biological implications. Significance: This work demonstrates the potential for deep learning analysis of histopathologic images to serve as a fast, low-cost method to assess genetic intratumoral heterogeneity. See related commentary by Song et al., p. 2672